Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05919108 |
| Title | Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Vanderbilt-Ingram Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Emory University/ Winship Cancer Institute | NOT_YET_RECRUITING | Atlanta | Georgia | 30322 | United States | Details |
| University of Pittsburgh Medical Center | NOT_YET_RECRUITING | Pittsburgh | Pennsylvania | 15213 | United States | Details |
| Vanderbilt University/Ingram Cancer Center | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| University of Texas, Southwestern | NOT_YET_RECRUITING | Dallas | Texas | 75390 | United States | Details |
| Baylor College of Medicine | NOT_YET_RECRUITING | Houston | Texas | 77030 | United States | Details |